We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+4.11%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$4.24B
AUM Growth
+$201M
Cap. Flow
+$47.9M
Cap. Flow %
1.13%
Top 10 Hldgs %
35.86%
Holding
675
New
21
Increased
101
Reduced
152
Closed
47

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$13.9M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.88M
3
CTSH icon
Cognizant
CTSH
+$8.57M
4
ABT icon
Abbott
ABT
+$5.85M
5
HAIN icon
Hain Celestial
HAIN
+$5.81M

Sector Composition

Rank Sector Weight
1 Technology 20.33%
2 Healthcare 18.48%
3 Consumer Staples 14.11%
4 Consumer Discretionary 10.62%
5 Industrials 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BPL
301
DELISTED
Buckeye Partners, L.P.
BPL
$118K ﹤0.01%
1,741
LBTYK icon
302
Liberty Global Class C
LBTYK
$3.45B
$116K ﹤0.01%
3,563
STE icon
303
Steris
STE
$23B
$116K ﹤0.01%
1,630
-3,615
-69% -$245K
TNL icon
304
Travel + Leisure Co
TNL
$4.56B
$115K ﹤0.01%
3,323
WPZ
305
DELISTED
Williams Partners L.P.
WPZ
$115K ﹤0.01%
5,632
SHW icon
306
Sherwin-Williams
SHW
$87.3B
$114K ﹤0.01%
1,200
ACAS
307
DELISTED
American Capital Ltd
ACAS
$114K ﹤0.01%
7,500
EFOR
308
Everforth Inc
EFOR
$1.35B
$111K ﹤0.01%
3,000
TVTY
309
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$110K ﹤0.01%
10,860
CP icon
310
Canadian Pacific Kansas City
CP
$82.4B
$108K ﹤0.01%
4,050
DGX icon
311
Quest Diagnostics
DGX
$26.3B
$107K ﹤0.01%
1,500
QQQ icon
312
Invesco QQQ Trust
QQQ
$485B
$106K ﹤0.01%
967
+367
+61% +$38.1K
HXL icon
313
Hexcel
HXL
$7.75B
$105K ﹤0.01%
2,400
-2,170
-47% -$91.2K
TV icon
314
Televisa
TV
$1.52B
$102K ﹤0.01%
3,700
+2,380
+180% +$62.4K
ETP
315
DELISTED
Energy Transfer Partners L.p.
ETP
$100K ﹤0.01%
3,090
-88
-3% -$2.45K
MYN icon
316
BlackRock MuniYield New York Quality Fund
MYN
$377M
$99K ﹤0.01%
7,110
-7,890
-53% -$109K
IRM icon
317
Iron Mountain
IRM
$37.1B
$94K ﹤0.01%
2,771
-481
-15% -$13.8K
KR icon
318
Kroger
KR
$35B
$94K ﹤0.01%
2,446
+166
+7% +$6.41K
PRGO icon
319
Perrigo
PRGO
$1.79B
$94K ﹤0.01%
731
-54
-7% -$7.38K
APH icon
320
Amphenol
APH
$208B
$93K ﹤0.01%
6,400
+4,000
+167% +$51.9K
MTB icon
321
M&T Bank
MTB
$36.8B
$93K ﹤0.01%
840
-393
-32% -$42.6K
BMRN icon
322
BioMarin Pharmaceuticals
BMRN
$13.3B
$91K ﹤0.01%
1,100
IWV icon
323
iShares Russell 3000 ETF
IWV
$20.5B
$88K ﹤0.01%
725
REGN icon
324
Regeneron Pharmaceuticals
REGN
$82.6B
$88K ﹤0.01%
245
AVY icon
325
Avery Dennison
AVY
$13.6B
$87K ﹤0.01%
1,200

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, Loring Wolcott & Coolidge Fiduciary Advisors held 675 positions worth $4.24B, up 5% from $4.04B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2016 filing shows 21 new, 101 increased, 152 reduced and 47 closed positions. Its largest new stake was Weyerhaeuser: 23,424 shares worth $726K. The largest sale was W.W. Grainger, an estimated $4.82M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q1 2016 buy was Weyerhaeuser: 23,424 shares worth $726K.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Celgene Corp in Q1 2016, an estimated $13.9M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q1 2016 reduction was W.W. Grainger, cutting an estimated $4.82M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited BOULDER BRANDS INC in Q1 2016, selling an estimated $4.32M.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 36% of its $4.24B portfolio in Q1 2016.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 21 new positions and closed 47 in Q1 2016.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 5% quarter-over-quarter to $4.24B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2016, filed 26 Apr 2016.